Drugmaker sues competitor for alleged sham litigation
Biopharmaceutical company Dicerna Pharmaceuticals has sued Alnylam Pharmaceuticals for allegedly using sham litigation and public announcements against Dicerna to illegally obtain market dominance.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10